has the experience
and resources to
handle complex claims involving prescription medication.
Trasylol Lawyers
The information on this page is provided for informational purposes only. As of 2011, the Simmons firm is no longer accepting cases involving Trasylol.
Filing a lawsuit
The Trasylol lawyers at the Simmons firm are investigating occurrences where heart surgery patients died after being treated with Trasylol, a protein that is used as medication administered by injection to reduce bleeding during complex surgery. Trasylol is manufactured by Bayer AG and has been used in nearly a third of all open heart surgeries in the US since 1993.
Trasylol FDA Warnings
In May 2008 Bayer Pharmaceuticals, the manufacturer of Trasylol (aprotinin), notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.
In November 2007, Bayer suspended the marketing of this drug until final results of the BART study became available. The BART study showed an increase in the risk of death with Trasylol compared with aminocaproic acid and tranexamic acid.
According to Dr. John K. Jenkins, director of the FDA's Office of New Drugs, the FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk.
Trasylol Heart Surgery Risks
Since the Bayer AG drug was brought to market in 1993, it has been used in a third of all open heart surgeries in the US. Unfortunately numerous studies have indicated that Trasylol puts such patients at a higher risk of death. An analysis of patients treated with the drug suggests that Trasylol could also increase the likelihood of serious kidney damage, congestive heart failure and strokes. Dr. Mangano, the author of a 2006 Trasylol study told “60 Minutes” that he believes Trasylol should have been taken off the market when he published his study in 2006.
The Simmons firm has represented thousands of pharmaceutical clients and recovered more than $100 million in verdicts and settlements.* We have experience in litigating complex medical matters. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs.
Trasylol Lawsuit
If you or someone you love were injured by Trasylol, you may be entitled to compensation.*
The Trasylol lawyers at the Simmons firm are investigating occurrences where heart surgery patients died after being treated with Trasylol, a protein that is used as medication administered by injection to reduce bleeding during complex surgery. Trasylol is manufactured by Bayer AG and has been used in nearly a third of all open heart surgeries in the US since 1993.WHAT IS TRASYLOL?
Trasylol is a protease inhibitor. It works to reduce inflammation during bypass surgery, reducing blood loss and the need for blood transfusions.1
TRASYLOL SIDE EFFECTS
Common side effects include:
Constipation; diarrhea; difficulty urinating; infection (eg, fever, chills, sore throat); lightheadedness; sleeplessness; vomiting.
Severe side effects include:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); asthma; chest pain; confusion; decreased urination; fast or irregular heartbeat; lung disorder; nausea; numbness of an arm or leg; one-sided weakness; severe stomach pain; sudden severe headache, dizziness, fainting, or vomiting; sudden weight gain; swelling of the hands, legs, or feet; vision or speech changes.2
See important information on surgery risks that may have initiated the need for possible Trasylol lawsuits.
FDA WARNING
November 5, 2007, Bayer suspended the marketing of Trasylol until final results of the BART study became available. The BART study showed an increase in the risk of death with Trasylol compared with aminocaproic acid and tranexamic acid. According to Dr. John K. Jenkins, director of the FDA's Office of New Drugs, the FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk.3
On May 15, 2008, Bayer Pharmaceuticals, the manufacturer of Trasylol (aprotinin), notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.4
Heart Surgery Risks Leading to Trasylol Lawsuits
Since the Bayer AG drug was brought to market in 1993, it has been used in one- third of all open heart surgeries in the US. Unfortunately numerous studies have indicated that Trasylol puts such patients at a higher risk of death. An analysis of patients treated with the drug suggests that Trasylol could also increase the likelihood of serious kidney damage, congestive heart failure and strokes. Dr. Mangano, the author of a 2006 Trasylol study told “60 Minutes” that he believes Trasylol should have been taken off the market when he published his study in 2006.1
* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.